Janney Montgomery Scott Downgrades Pacira Pharmaceuticals (PCRX) to Sell
Tweet
Share
E-mail
Get Alerts PCRX Hot Sheet
Price: $25.76 -0.27%
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Janney Montgomery Scott downgraded Pacira Pharmaceuticals (NASDAQ: PCRX) from Neutral to Sell.
For an analyst ratings summary and ratings history on Pacira Pharmaceuticals click here. For more ratings news on Pacira Pharmaceuticals click here.
Shares of Pacira Pharmaceuticals closed at $31.85 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PharmaCorp Rx Inc. Announces Board and Committee Changes
- Freedom Broker Downgrades Workday (WDAY) to Hold
- Erste Group Downgrades UnitedHealth Group (UNH) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Janney Montgomery ScottSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
